ClinicalTrials.gov
public full text
Public Domain
An Open Trial of Metacognitive Therapy for Anxiety and Depression in Cancer
Survival rates in cancer continue to improve, with over 2 million adult cancer survivors in the United Kingdom, projected to increase to 4 million by 2030. Around 25% of these survivors require treatment for clinical levels of emotional distress. The investigators will conduct a phase I open trial to test the potential efficacy of MCT in cancer survivors.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Mind Programme for Women With Breast Cancer#858885
- Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort#1101445
- MBCT and CBT for Depression in Patients After Cancer: a Randomized Controlled Trial#853998
- Online Treatment of Cognitive Impairment and Insomnia in Cancer Survivors#1104316
- Early Rehabilitation of Cancer Patients#1111751
Record · ID 884368
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive